OTCMKTS:BVNRY Bavarian Nordic (BVNRY) Stock Price, News & Analysis $10.69 +0.09 (+0.80%) As of 09/21/2026 03:14 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsNews and TrendsShort Interest About Bavarian Nordic Stock (OTCMKTS:BVNRY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Bavarian Nordic alerts:Sign Up Key Stats Today's Range$10.69▼$10.7250-Day Range$8.76▼$11.4452-Week Range$8.67▼$13.00Volume3,075 shsAverage Volume1,638 shsMarket Capitalization$2.54 billionP/E Ratio10.80Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Bavarian Nordic A/S (OTCMKTS:BVNRY) is a Danish biotechnology company that develops, manufactures and commercializes vaccines for infectious diseases. The company serves government agencies, military organizations, healthcare providers and travelers, with products distributed across Europe, North America and other international markets. Its best-known product is JYNNEOS, also marketed as IMVAMUNE or IMVANEX in certain regions, a non-replicating smallpox and mpox vaccine. Bavarian Nordic also offers vaccines for rabies and tick-borne encephalitis, including RabAvert and Rabipur for rabies prevention and Encepur for protection against tick-borne encephalitis. Its portfolio includes vaccines used in routine, travel and outbreak-response settings. Founded in 1994 and headquartered in Hellerup, Denmark, Bavarian Nordic has developed specialized vaccine production capabilities and works with public-sector customers on preparedness for infectious disease threats. The company also conducts research and development aimed at expanding its vaccine portfolio and addressing additional unmet needs in infectious disease prevention.AI Generated. May Contain Errors. Read More Receive BVNRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bavarian Nordic and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BVNRY Stock News HeadlinesBavarian Nordic (OTCMKTS:BVNRY) Short Interest UpdateSeptember 15, 2026 | americanbankingnews.comBavarian Nordic Earnings Call Signals Profitable GrowthAugust 29, 2026 | tipranks.comTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.September 22 at 1:00 AM | Behind the Markets (Ad)Bavarian Nordic A/S (BVNRY) Q2 2026 Earnings Call TranscriptAugust 21, 2026 | seekingalpha.comGlobal warming widens spread of TBE, chikungunya, Bavarian Nordic boss saysAugust 21, 2026 | reuters.comBavarian Nordic AS ADR BVNRYJuly 4, 2026 | morningstar.comMBavarian Nordic A/SMay 23, 2026 | cnbc.comBavarian Nordic Lifts Guidance After Robust Q1 CallMay 13, 2026 | tipranks.comSee More Headlines BVNRY Stock Analysis - Frequently Asked Questions How have BVNRY shares performed this year? Bavarian Nordic's stock was trading at $9.9260 at the beginning of 2026. Since then, BVNRY stock has increased by 7.7% and is now trading at $10.69. How were Bavarian Nordic's earnings last quarter? Bavarian Nordic (OTCMKTS:BVNRY) announced its quarterly earnings data on Friday, August, 21st. The company reported $0.46 earnings per share for the quarter. The business had revenue of $316.47 million for the quarter. Bavarian Nordic had a net margin of 24.36% and a trailing twelve-month return on equity of 11.97%. How do I buy shares of Bavarian Nordic? Shares of BVNRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/21/2026Today9/22/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:BVNRY CIKN/A Webwww.bavarian-nordic.com Phone(453) 326-8383Fax45-3326-8380Employees1,692Year Founded1994Profitability EPS (Trailing Twelve Months)$0.99 Trailing P/E Ratio10.80 Forward P/E RatioN/A P/E GrowthN/ANet Income$208.23 million Net Margins24.36% Pretax Margin30.86% Return on Equity11.97% Return on Assets10.55% Debt Debt-to-Equity RatioN/A Current Ratio6.53 Quick Ratio3.91 Sales & Book Value Annual Sales$945.43 million Price / Sales2.69 Cash Flow$1.36 per share Price / Cash Flow7.88 Book Value$8.20 per share Price / Book1.30Miscellaneous Outstanding Shares237,800,000Free FloatN/AMarket Cap$2.54 billion OptionableNot Optionable Beta1.20 Social Links 10 Best Stocks to Own - Fall 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (OTCMKTS:BVNRY) was last updated on 9/22/2026 by MarketBeat.com Staff. From Our Partners10% yields… from a gold security?Most stocks yield under 2%. Even gold stocks average less than 1%. One gold security, backed by one of the wor...Golden Portfolio | Sponsored$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bavarian Nordic Please log in to your account or sign up in order to add this asset to your watchlist. Share Bavarian Nordic With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.